/
/
/

Cohance Lifesciences Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019
₹422 Cr₹619 Cr₹545 Cr₹556 Cr₹549 Cr₹840 Cr₹676 Cr₹604 Cr₹488 Cr₹253 Cr₹220 Cr₹231 Cr₹348 Cr₹369 Cr₹354 Cr₹278 Cr₹339 Cr₹364 Cr₹392 Cr₹301 Cr₹264 Cr₹259 Cr₹275 Cr₹237 Cr₹238 Cr₹185 Cr₹179 Cr₹273 Cr₹197 Cr₹251 Cr
₹12 Cr-₹2 Cr₹6 Cr₹16 Cr₹14 Cr₹12 Cr₹22 Cr₹16 Cr₹19 Cr₹17 Cr₹14 Cr₹20 Cr₹11 Cr₹11 Cr₹13 Cr₹11 Cr₹11 Cr₹17 Cr₹65 Cr₹5 Cr₹6 Cr₹3 Cr₹5 Cr₹36 L₹6 Cr₹5 Cr₹5 Cr₹5 Cr₹2 Cr₹41 L
₹435 Cr₹617 Cr₹551 Cr₹571 Cr₹563 Cr₹852 Cr₹698 Cr₹620 Cr₹507 Cr₹270 Cr₹234 Cr₹251 Cr₹358 Cr₹381 Cr₹367 Cr₹289 Cr₹350 Cr₹381 Cr₹456 Cr₹306 Cr₹270 Cr₹262 Cr₹280 Cr₹238 Cr₹244 Cr₹190 Cr₹184 Cr₹278 Cr₹200 Cr₹251 Cr
₹471 Cr₹572 Cr₹496 Cr₹479 Cr₹482 Cr₹665 Cr₹482 Cr₹436 Cr₹394 Cr₹197 Cr₹167 Cr₹144 Cr₹192 Cr₹210 Cr₹219 Cr₹191 Cr₹199 Cr₹217 Cr₹216 Cr₹188 Cr₹158 Cr₹174 Cr₹146 Cr₹147 Cr₹134 Cr₹115 Cr₹105 Cr₹153 Cr₹100 Cr₹135 Cr
₹13 Cr₹97 Cr₹102 Cr₹137 Cr₹126 Cr₹241 Cr₹259 Cr₹222 Cr₹145 Cr₹90 Cr₹80 Cr₹118 Cr₹178 Cr₹183 Cr₹160 Cr₹111 Cr₹162 Cr₹174 Cr₹251 Cr₹127 Cr₹120 Cr₹97 Cr₹143 Cr₹98 Cr₹117 Cr₹82 Cr₹84 Cr₹131 Cr₹105 Cr₹122 Cr
₹7 Cr₹9 Cr₹9 Cr₹9 Cr₹10 Cr₹10 Cr₹11 Cr₹10 Cr₹10 Cr₹2 Cr₹2 Cr₹1 Cr₹2 Cr₹5 Cr₹1 Cr₹29 L₹1 Cr₹2 Cr₹74 L₹1 Cr₹2 Cr₹2 Cr₹3 Cr₹3 Cr₹3 Cr₹7 Cr₹8 Cr₹4 Cr₹4 Cr₹2 Cr
-₹43 Cr₹20 Cr₹41 Cr₹84 Cr₹63 Cr₹161 Cr₹205 Cr₹174 Cr₹103 Cr₹71 Cr₹65 Cr₹105 Cr₹164 Cr₹166 Cr₹146 Cr₹98 Cr₹149 Cr₹161 Cr₹239 Cr₹116 Cr₹109 Cr₹87 Cr₹132 Cr₹88 Cr₹108 Cr₹68 Cr₹71 Cr₹121 Cr₹96 Cr₹115 Cr
-₹45 Cr₹8 Cr₹29 Cr₹66 Cr₹46 Cr₹117 Cr₹153 Cr₹138 Cr₹75 Cr₹53 Cr₹47 Cr₹80 Cr₹121 Cr₹124 Cr₹108 Cr₹72 Cr₹108 Cr₹92 Cr₹160 Cr₹80 Cr₹81 Cr₹64 Cr₹98 Cr₹65 Cr₹81 Cr₹53 Cr₹52 Cr₹89 Cr₹75 Cr₹75 Cr

Share Price Live Stats

Open (₹)463.30
Volume (₹)3.03 L
High (₹)470.00
Upper Circuit553.00
Low (₹)458.50
Lower Circuit368.70
Prev Close460.85
52W High (₹)1,038.90
Price462.95
52W Low (₹)266.70

Share Market Cap & Key Ratios Overview

M.Cap (₹)17605.20 Cr
Div. Yield (%)0.00
PE Ratio165.73
Debt to Equity0.04
Price to Book2.97
Book Value101.76
EPS (TTM)2.78
Face Value1.00
ROE (%)4.02

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
COHANCENSE
LTP
1W Low
1W High
Market cap (₹)
1904.8-15.2 (-0.79%)
1902
1984.80
4,56,833Cr
9211.5-27.5 (-0.30%)
9087
9467
2,45,426Cr
4894.5-155.5 (-3.08%)
4885
5066
1,87,320Cr
1133.2-57.8 (-4.85%)
1125.10
1187
1,13,217Cr
1391.5-32 (-2.25%)
1376.70
1426.10
1,12,212Cr
1853.9-84.6 (-4.36%)
1811.70
1949
1,01,155Cr
2123-48.5 (-2.23%)
2118.10
2192
97,626Cr
2349.2-33.7 (-1.41%)
2341.20
2419.20
96,859Cr
1163.9-14.1 (-1.20%)
1154.40
1179.90
96,406Cr
1656.5+11.2 (0.68%)
1622.60
1717
93,614Cr
462.95+13.05 (2.90%)
444
476.50
17,605Cr

Key Highlights of Cohance Lifesciences Ltd’s P&L

In 2026-03-31, Cohance Lifesciences Ltd reported total revenue of ₹2302.64Cr, compared with ₹2677.71Cr in 2025-03-31, reflecting Cohance Lifesciences Ltd turnover.

Depreciation was ₹187.33Cr and finance costs were ₹37.24Cr in 2026-03-31

Profit Before Tax (PBT) has been ₹207.04Cr in 2026-03-31 as compared to ₹642.63Cr in 2025-03-31.

Net Profit (PAT) was ₹179.23Cr in 2026-03-31 compared with ₹487.34Cr in 2025-03-31.

Earnings per share (EPS) were ₹4.68 in 2026-03-31, compared with ₹19.14 in 2025-03-31.